PHA-739358 for the Treatment of Multiple Myeloma

Summary

The purpose of this study is to determine the antitumor activity of PHA-739358 as single agent IV infusion in adult patients with Multiple Myeloma who have a history of at least 2 previous lines of treatment for the disease.

Timeline

Start

2008-10

Primary completion

2009-09

Completion

2010-09

Outcome

Outcome not reported

Stopped (Enrollment): “Low recruitment rate”

Drugs

Indications